H. Mangos

Benign FGB (148Lys→Asn, and 448Arg→Lys), and novel causative γ211Tyr→His mutation distinguished by time of flight mass spectrometry in a family with hypofibrinogenaemia

S. Brennan, J. Faed, H. Mangos, 2013, Thrombosis and Haemostasis.

Diagnosis and Management of Adult Patients with von Willebrand Disease in South Australia

E. Duncan, J. Lloyd, S. Mcrae, 2011, Seminars in thrombosis and hemostasis.

Daclizumab has poor efficacy in steroid-refractory severe acute graft-versus-host disease: a single centre experience with 12 allograft patients

C. Hui, P. Bardy, L. To, 2008, Bone Marrow Transplantation.

Acquired Hemophilia A following Pfizer-BioNTech SARS CoV-2 mRNA vaccine, successfully treated with prednisolone and rituximab

P. Gilbar, H. Mangos, Philip Wong, 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Temozolomide-induced aplastic anaemia: Case report and review of the literature

P. Gilbar, H. Mangos, Khageshwor Pokharel, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

A hemophilic son of a hemophiliac: did my son inherit my hemophilia?

G. Casey, V. Williams, H. Tapp, 2007, Journal of thrombosis and haemostasis : JTH.

Successful treatment of transplant-associated microangiopathy with rituximab.

P. Ganly, H. Marr, E. Merriman, 2009, The New Zealand medical journal.